Paul Bălănescu Selected Research

Paul Bălănescu Research Topics

6	Systemic Scleroderma (Systemic Sclerosis) 06/2021 - 08/2014
4	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2016
3	Overweight 01/2020 - 03/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2020 - 03/2020
1	Parkinson Disease (Parkinson's Disease) 03/2022
1	Parkinsonian Disorders (Parkinsonism) 03/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 02/2021
1	Vascular Diseases (Vascular Disease) 10/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020
1	Neurologic Manifestations (Neurological Manifestations) 10/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Fibrosis (Cirrhosis) 09/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2018
1	Alcoholic Fatty Liver 01/2016
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2015
1	Inflammation (Inflammations) 09/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2014

9	Biomarkers (Surrogate Marker)IBA 06/2021 - 08/2014
2	LipidsIBA 03/2018 - 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2022
1	Antihypertensive Agents (Antihypertensives)IBA 03/2022
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2022
1	DiureticsIBA 03/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020
1	CollagenIBA 10/2020
1	GlucocorticoidsIBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020
1	LumicanIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 03/2018
1	Interleukin-17 (Interleukin 17)IBA 12/2017
1	reticulocalbinIBA 01/2016
1	Ethanolamine (Colamine)IBA 10/2015
1	AntibodiesIBA 10/2015
1	Antiphospholipid AntibodiesIBA 10/2015
1	Complement System Proteins (Complement)IBA 10/2015
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 09/2014
1	Biological ProductsIBA 08/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	CytokinesIBA 01/2014

2	Therapeutics 10/2020 - 03/2020